Drawing for A HEALTHIER HOSPITAL BEGINS WITH A HEALTHIER LAB

USPTO serial 86861464

A HEALTHIER HOSPITAL BEGINS WITH A HEALTHIER LAB

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HERMAN, RUSS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with A HEALTHIER HOSPITAL BEGINS WITH A HEALTHIER LAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

MICHELE H. BOWMAN ABBOTT LABORATORIESAP6C/377100 ABBOTT PARK ROADABBOTT PARK, IL 60064

Goods and services

ClassDescriptionStatusFirst use
035Conducting business operations research and analysis in connection with laboratories and healthcare facilities in the fields of workflow and personnel management and issuing reports in connection therewithACTIVE—
042Consulting regarding medical diagnostic software; consulting regarding medical software; consulting regarding software in the field of health; installation, maintenance and repair of software related to medical diagnostic instruments; providing technical support, namely, troubleshooting regarding laboratory software in the field of medical diagnostics; remote electronic operational monitoring of diagnostic laboratory systems, laboratory automation systems, and medical diagnostic instruments; providing platform as a service (PAAS) featuring a web-based software platform for laboratory and medical diagnostic information management; platform as a service (PAAS) featuring providing a web-based software platform in the field of health, for monitoring laboratory operations; platform as a service (PAAS) featuring providing a web-based software platform in the field of medical diagnostics, for analyzing bodily fluid and tissue samples; software as a service (SAAS) services featuring software for laboratory and diagnostic equipment information management, monitoring and analysis in the field of medical diagnostics; software as a service (SAAS) featuring software for laboratory and diagnostic equipment information management, monitoring and analysis services in the field of health; platform as a service (PAAS) featuring software platforms for laboratory and diagnostic equipment information management, monitoring and analysis in the field of medical diagnostics; platform as a service (PAAS) featuring software platforms for laboratory and diagnostic equipment information management, monitoring and analysis in the field of health, for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; conducting medical diagnostic testing facility evaluations to assess, quality, environmental sustainability, waste, efficiency, operational downtime, flexibility and agility, namely, quality management evaluations of the medical diagnostic facilities of others to assess steps required to attain optimal efficiency. conducting laboratory, healthcare facility and healthcare system operational research and analyzing and reporting regarding laboratory, healthcare facility and healthcare system operational performance, namely, research, analysis and reporting regarding the performance and efficiency of laboratory instruments, medical diagnostic instruments and accompanying computer systems; conducting operational research, monitoring and analysis regarding medical diagnostic instruments, tests and assays, namely, evaluations of the quality and performance of medical diagnostic instruments, tests and assays; analyzing and reporting operational research data, namely, analyzing and reporting information regarding the performance of medical diagnostic instruments, tests and assays; monitoring, analyzing and reporting services, namely, quality control in the field of medical laboratory equipment operations, medical laboratory inventory management, medical laboratory quality management; data and information management, tracking, analyzing and reporting in the field of medical diagnostics, namely, tracking, analyzing and reporting of performance data for medical diagnostic equipment using computers and sensorsACTIVE—
045Conducting medical diagnostic testing facility evaluations to assess safety, namely, facility inspection for safety purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 4, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 4, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 27, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 25, 2018EX2GSOU EXTENSION 2 GRANTED—
Jul 25, 2018EXT2SOU EXTENSION 2 FILED—
Jul 25, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 25, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2018EX1GSOU EXTENSION 1 GRANTED—
Jan 23, 2018EXT1SOU EXTENSION 1 FILED—
Jan 23, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 1, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Apr 24, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 24, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 24, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 24, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 20, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2016DOCKASSIGNED TO EXAMINER—
Jan 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance